Výsledky vyhledávání - "C M, Woodroffe"

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin’s lymphoma

Autor: D. R. Norfolk, C. Stack, A. V. Simmons, Andrew Jack, C. M. Woodroffe, D. L. Barnard, N. P. Bailey, M. H. Cullen, John Fletcher, Janet A. Dunn, E. Bessell, J. Farish, Robert Grieve, N. S. A. Stuart, J. A. Child

Publikováno v: Annals of Oncology. 9:633-638

Background: Weekly alternating regimen known as CAPOMEt is compared to standard cyclical chemotherapy (CHOP-Mtx) in aggressive non-Hodgkin's lymphoma (NHL). Patients and methods: Three hundred and eighty-one patients with aggressive NHL were randomis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a8950e28f5d63abe19d8b24a1ea85f75
https://doi.org/10.1023/a:1008276700860

Zobrazit plný text záznamu

Long-term toxicity of chemotherapy for testicular cancer--the cost of cure

Autor: R. Grundy, N. S. A. Stuart, Michael Cullen, C. M. Woodroffe

Publikováno v: British Journal of Cancer

Twenty-seven patients cured of advanced testicular cancer by cisplatin-based chemotherapy have been assessed, a median of 30 months after start of treatment, for the long-term effects of such treatment on renal, endocrine, audiometric, reproductive a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53f608537f508c14f06fd44397ee5be4
http://europepmc.org/articles/PMC1971302

Zobrazit plný text záznamu

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group

Autor: N P, Bailey, N S, Stuart, E M, Bessell, J A, Child, D, Norfolk, J, Fletcher, R J, Grieve, A V, Simmons, D L, Barnard, A, Jack, J, Farish, J, Dunn, C M, Woodroffe, C, Stack, M H, Cullen

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 9(6)

Weekly alternating regimen known as CAPOMEt is compared to standard cyclical chemotherapy (CHOP-Mtx) in aggressive non-Hodgkin's lymphoma (NHL).Three hundred and eighty-one patients with aggressive NHL were randomised to receive either cyclophosphami

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0bf246ba8d9dbc3513016dc6765aa6a8
https://pubmed.ncbi.nlm.nih.gov/9681077

Zobrazit plný text záznamu

ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group

Autor: A. Murphy, N. S. A. Stuart, J. A. Child, C. M. Woodroffe, John Fletcher, E. L. Jones, Robert Grieve, Michael Cullen, G. R. P. Blackledge

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 12(4)

PURPOSE The United Kingdom Central Lymphoma Group (CLG) has modified mechlorethamine, vincristine, procarbazine, and prednisone/doxorubicin, bleomycin, vinblastine, and dacarbazine (MOPP/ABVD) by substituting mechlorethamine with chlorambucil and dac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d480f285a62824564d962ba9ef5a5c4c
https://pubmed.ncbi.nlm.nih.gov/7512132

Zobrazit plný text záznamu

Quality of life after treatment for testicular cancer--the patient's view

Autor: N.S.A. Stuart, R. Grundy, C. M. Woodroffe, M. H. Cullen

Publikováno v: European journal of cancer (Oxford, England : 1990). 26(3)

Twenty-eight patients cured of testicular cancer by cisplatin-based chemotherapy were asked for their own views of the long-term psychological and social effects of their treatment. Their views were compared with a group of 34 testicular cancer patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca590cb8a7f6db70e5944280183176dd
https://pubmed.ncbi.nlm.nih.gov/2141485

Zobrazit plný text záznamu

The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial

Autor: K. Palmer, J. Sharpe, C. M. Woodroffe, K. Kelly, N. S. A. Stuart, G. R. P. Blackledge, M. E. R. O'brien, Michael Cullen, C. Burman

Publikováno v: British Journal of Cancer

High dose metoclopramide is an effective anti-emetic for use with cisplatin containing chemotherapy regimens but can cause extrapyramidal reactions. Lorazepam and dexamethasone are increasingly being used to alleviate chemotherapy induced emesis. Thi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f20324f053c2ef907e38a467627d1c93
https://doi.org/10.1038/bjc.1989.354

Zobrazit plný text záznamu

Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive disease

Autor: M H, Cullen, S R, Smith, G F, Benfield, C M, Woodroffe

Publikováno v: Cancer treatment reports. 71(12)

We have evaluated the orally active anthracycline idarubicin at a dose of 40 mg/m2 in divided doses over 24 hours in 21 previously untreated patients with extensive-stage small cell carcinoma of the lung (SCCL). Subsequent iv therapy was cyclophospha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b6519d2c3aad58389b05194a61d28014
https://pubmed.ncbi.nlm.nih.gov/2825991

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání